1994 Journal Article The antinociceptive potencies of oxycodone, noroxycodone and morphine after intracerebroventricular administration to ratsLeow, K P and Smith, M T (1994). The antinociceptive potencies of oxycodone, noroxycodone and morphine after intracerebroventricular administration to rats. Life sciences, 54 (17), 1229-36. |
1994 Journal Article The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complexBartlett, SE, Cramond, T and Smith, MT (1994). The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex. Life Sciences, 54 (10), 687-694. doi: 10.1016/0024-3205(94)00552-4 |
1994 Journal Article The Antinociceptive Potencies of Oxycodone, Noroxycodone and Morphine After Intracerebroventricular Administration to RatsLeow, KP and Smith, MT (1994). The Antinociceptive Potencies of Oxycodone, Noroxycodone and Morphine After Intracerebroventricular Administration to Rats. Life Sciences, 54 (17), 1229-1236. doi: 10.1016/0024-3205(94)00849-3 |
1993 Journal Article Determination of the Serum-Protein Binding of Oxycodone and Morphine Using UltrafiltrationLeow, KP, Wright, Awe, Cramond, T and Smith, MT (1993). Determination of the Serum-Protein Binding of Oxycodone and Morphine Using Ultrafiltration. Therapeutic Drug Monitoring, 15 (5), 440-447. doi: 10.1097/00007691-199310000-00014 |
1992 Journal Article Comparative Oxycodone Pharmacokinetics in Humans After Intravenous, Oral, and Rectal AdministrationLeow, KP, Smith, MT, Watt, JA, Williams, BE and Cramond, T (1992). Comparative Oxycodone Pharmacokinetics in Humans After Intravenous, Oral, and Rectal Administration. Therapeutic Drug Monitoring, 14 (6), 479-484. doi: 10.1097/00007691-199212000-00008 |
1992 Journal Article Single-Dose and Steady-State Pharmacokinetics and Pharmacodynamics of Oxycodone in Patients with CancerLeow, KP, Smith, MT, Williams, B and Cramond, T (1992). Single-Dose and Steady-State Pharmacokinetics and Pharmacodynamics of Oxycodone in Patients with Cancer. Clinical Pharmacology & Therapeutics, 52 (5), 487-495. doi: 10.1038/clpt.1992.176 |
1992 Journal Article Comments on Gong et al., PAIN, 48 (1992) 249-255Cramond, Tess, Smith, Maree T. and Watt, Julie A. (1992). Comments on Gong et al., PAIN, 48 (1992) 249-255. Pain, 51 (1), 124-125. doi: 10.1016/0304-3959(92)90022-4 |
1991 Journal Article Quantitation of oxycodone in human plasma using high–performance liquid chromatography with electrochemical detectionSmith M.T., Watt J.A., Mapp G.P. and Cramond T. (1991). Quantitation of oxycodone in human plasma using high–performance liquid chromatography with electrochemical detection. Therapeutic Drug Monitoring, 13 (2), 126-130. doi: 10.1097/00007691-199103000-00007 |
1990 Journal Article Morphine-3-glucuronide - a potent antagonist of morphine analgesiaSmith M.T., Watt J.A. and Cramond T. (1990). Morphine-3-glucuronide - a potent antagonist of morphine analgesia. Life Sciences, 47 (6), 579-585. doi: 10.1016/0024-3205(90)90619-3 |
1990 Journal Article Dose-dependent pharmacokinetics of caffeine in humans: Relevance as a test of quantitative liver functionCheng W.S.C., Murphy T.L., Smith M.T., Cooksley W.G.E., Halliday J.W. and Powell L.W. (1990). Dose-dependent pharmacokinetics of caffeine in humans: Relevance as a test of quantitative liver function. Clinical Pharmacology and Therapeutics, 47 (4), 516-524. doi: 10.1038/clpt.1990.66 |
1986 Journal Article Correlations between in vitro dissolution, in vivo bioavailability and hypoglycaemic effect of oral glibenclamideChalk, J.B., Patterson, M., Smith, M.T. and Eadie, M.J. (1986). Correlations between in vitro dissolution, in vivo bioavailability and hypoglycaemic effect of oral glibenclamide. European Journal of Clinical Pharmacology, 31 (2), 177-182. doi: 10.1007/BF00606655 |
1985 Journal Article Organ and tissue preservation for transplantation: Monitoring by 31P nuclear magnetic resonanceMarshall V., Ross B., Smith M., Bartlett S. and Freeman D. (1985). Organ and tissue preservation for transplantation: Monitoring by 31P nuclear magnetic resonance. Transplantation Proceedings, 17 (2), 1693-1696. |
1985 Journal Article A sensitive liquid chromatographic assay for plasma aspirin and salicylate concentrations after low doses of aspirinBrandon R.A., Eadie M.J. and Smith M.T. (1985). A sensitive liquid chromatographic assay for plasma aspirin and salicylate concentrations after low doses of aspirin. Therapeutic Drug Monitoring, 7 (2), 216-221. doi: 10.1097/00007691-198506000-00014 |
1984 Journal Article Bioavailability and pharmacokinetics of phenytoin during pregnancyLander C.M., Smith M.T., Chalk J.B., de Wytt C., Symoniw P., Livingstone I. and Eadie M.J. (1984). Bioavailability and pharmacokinetics of phenytoin during pregnancy. European Journal of Clinical Pharmacology, 27 (1), 105-110. doi: 10.1007/BF00553163 |
1984 Journal Article Pharmacokinetics of midazolam in the agedSmith M.T., Heazlewood V., Eadie M.J., Brophy T.O. and Tyrer J.H. (1984). Pharmacokinetics of midazolam in the aged. European Journal of Clinical Pharmacology, 26 (3), 381-388. doi: 10.1007/BF00548771 |
1983 Journal Article Propranolol in pregnancy three year prospective studyLivingstone I., Craswell P.W., Bevan E.B., Smith M.T. and Eadie M.J. (1983). Propranolol in pregnancy three year prospective study. Hypertension in Pregnancy, B2 (2), 341-350. doi: 10.3109/10641958309006092 |
1983 Journal Article Metabolism of propranolol in the human maternal-placental-foetal unitSmith, MT, Livingstone, I, Eadie, MJ, Hooper, WD and Triggs, EJ (1983). Metabolism of propranolol in the human maternal-placental-foetal unit. European Journal of Clinical Pharmacology, 24 (6), 727-732. doi: 10.1007/BF00607078 |
1983 Journal Article Propranolol, Propranolol Glucuronide, and Naphthoxylactic Acid in Breast-Milk and PlasmaSmith, MT, Livingstone, I, Hooper, WD, Eadie, MJ and Triggs, EJ (1983). Propranolol, Propranolol Glucuronide, and Naphthoxylactic Acid in Breast-Milk and Plasma. Therapeutic Drug Monitoring, 5 (1), 87-93. doi: 10.1097/00007691-198303000-00008 |
1983 Journal Article Chronic propranolol administration during pregnancy - Maternal pharmacokineticsSmith, MT, Livingstone, I, Eadie, MJ, Hooper, WD and Triggs, EJ (1983). Chronic propranolol administration during pregnancy - Maternal pharmacokinetics. European Journal of Clinical Pharmacology, 25 (4), 481-490. doi: 10.1007/BF00542115 |
1981 Journal Article The pharmacokinetics of midazolam in manSmith, MT, Eadie, MJ and Brophy, TO (1981). The pharmacokinetics of midazolam in man. European Journal of Clinical Pharmacology, 19 (4), 271-278. doi: 10.1007/BF00562804 |